Distribution of brain sodium accumulation correlates with disability in multiple sclerosis: a cross-sectional 23Na MR imaging study.

PURPOSE To quantify brain sodium accumulations and characterize for the first time the spatial location of sodium abnormalities at different stages of relapsing-remitting (RR) multiple sclerosis (MS) by using sodium 23 ((23)Na) magnetic resonance (MR) imaging. MATERIALS AND METHODS This study was approved by the local committee on ethics, and written informed consent was obtained from all participants. Three-dimensional (23)Na MR imaging data were obtained with a 3.0-T unit in two groups of patients with RR MS-14 with early RR MS (disease duration <5 years) and 12 with advanced RR MS (disease duration >5 years)-and 15 control subjects. Quantitative assessment of total sodium concentration (TSC) levels within compartments (MS lesions, white matter [WM], and gray matter [GM]) as well as statistical mapping analyses of TSC abnormalities were performed. RESULTS TSC was increased inside demyelinating lesions in both groups of patients, whereas increased TSC was observed in normal-appearing WM and GM only in those with advanced RR MS. In patients, increased TSC inside GM was correlated with disability (as determined with the Expanded Disability Status Scale [EDSS] score; P = .046, corrected) and lesion load at T2-weighted imaging (P = .003, corrected) but not with disease duration (P = .089, corrected). Statistical mapping analysis showed confined TSC increases inside the brainstem, cerebellum, and temporal poles in early RR MS and widespread TSC increases that affected the entire brain in advanced RR MS. EDSS score correlated with TSC increases inside motor networks. CONCLUSION TSC accumulation dramatically increases in the advanced stage of RR MS, especially in the normal-appearing brain tissues, concomitant with disability. Brain sodium MR imaging may help monitor the occurrence of tissue injury and disability.

[1]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[2]  J. Ra,et al.  In Vivo NMR Imaging of Sodium‐23 in the Human Head , 1985, Journal of computer assisted tomography.

[3]  S. Waxman,et al.  Ion channels in spinal cord astrocytes in vitro. II. Biophysical and pharmacological analysis of two Na+ current types. , 1992, Journal of neurophysiology.

[4]  S. Waxman,et al.  Astrocyte Na+ channels are required for maintenance of Na+/K(+)-ATPase activity , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[5]  Hans Lassmann,et al.  Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.

[6]  P. Matthews,et al.  Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. , 2000, Brain : a journal of neurology.

[7]  B. Trapp,et al.  Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease , 2003, Journal of the Neurological Sciences.

[8]  Stephen G Waxman,et al.  Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. , 2004, Brain : a journal of neurology.

[9]  Peter K. Stys,et al.  General mechanisms of axonal damage and its prevention , 2005, Journal of the Neurological Sciences.

[10]  Hans Lassmann,et al.  Cortical demyelination and diffuse white matter injury in multiple sclerosis. , 2005, Brain : a journal of neurology.

[11]  J. Ranjeva,et al.  Local tissue damage assessed with statistical mapping analysis of brain magnetization transfer ratio: relationship with functional status of patients in the earliest stage of multiple sclerosis. , 2005, AJNR. American journal of neuroradiology.

[12]  Costin Tanase,et al.  Loss of cell ion homeostasis and cell viability in the brain: what sodium MRI can tell us. , 2005, Current topics in developmental biology.

[13]  Stephen G. Waxman,et al.  Axonal conduction and injury in multiple sclerosis: the role of sodium channels , 2006, Nature Reviews Neuroscience.

[14]  David H. Miller,et al.  Selective magnetization transfer ratio decrease in the visual cortex following optic neuritis. , 2006, Brain : a journal of neurology.

[15]  R. Rudick,et al.  Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients , 2006, Annals of neurology.

[16]  Hans Lassmann,et al.  The Immunopathology of Multiple Sclerosis: An Overview , 2007, Brain pathology.

[17]  Frederik Barkhof,et al.  Extensive Hippocampal Demyelination in Multiple Sclerosis , 2007, Journal of neuropathology and experimental neurology.

[18]  Hans Lassmann,et al.  Widespread Demyelination in the Cerebellar Cortex in Multiple Sclerosis , 2007, Brain pathology.

[19]  Kenneth J. Smith,et al.  Sodium Channels and Multiple Sclerosis: Roles in Symptom Production, Damage and Therapy , 2007, Brain pathology.

[20]  D. Turnbull,et al.  Review: Mitochondria and disease progression in multiple sclerosis , 2008, Neuropathology and applied neurobiology.

[21]  S. Waxman Mechanisms of Disease: sodium channels and neuroprotection in multiple sclerosis—current status , 2008, Nature Clinical Practice Neurology.

[22]  Pierrick Coupé,et al.  An Optimized Blockwise Nonlocal Means Denoising Filter for 3-D Magnetic Resonance Images , 2008, IEEE Transactions on Medical Imaging.

[23]  D. Chard,et al.  Grey matter pathology in clinically early multiple sclerosis: Evidence from magnetic resonance imaging , 2009, Journal of the Neurological Sciences.

[24]  Wolfhard Semmler,et al.  Sodium MRI using a density‐adapted 3D radial acquisition technique , 2009, Magnetic resonance in medicine.

[25]  S. Waxman,et al.  Astrocytes within multiple sclerosis lesions upregulate sodium channel Nav1.5. , 2010, Brain : a journal of neurology.

[26]  B Stoeckel,et al.  Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla. , 2010, Brain : a journal of neurology.

[27]  H. Lassmann Axonal and neuronal pathology in multiple sclerosis: What have we learnt from animal models , 2010, Experimental Neurology.

[28]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[29]  David H. Miller,et al.  Energy failure in multiple sclerosis and its investigation using MR techniques , 2011, Journal of Neurology.

[30]  A. Bar-Or,et al.  Targeting Progressive Neuroaxonal Injury , 2011, CNS drugs.